Other functions preclinical prevent program toxicology and pharmacology studies
Ended Awarded Last action
- Contract number
- HHSN261201500026I
- Awardee
-
University Of Illinois UEI W8XEAJDKMXH3 Part of University Of Illinois
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $4,207,592 obligated
Award facts
- Opportunity
-
- N01CN4500045 Solicitation number
- Combined order value
- $4,207,592 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 22% used
- $19,000,000.00
- Maximum order
- $5,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The University of Illinois, doing business as The Board of Trustees of the University of Illinois, has been awarded an Indefinite Delivery Contract (IDC) from the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. The $19,000,000 multiple-award IDC, designated as the "PREVENT Toxicology and Pharmacology Testing (PREVENT TOX)" program, aims to provide a structured approach to the development of cancer drugs and vaccines from discovery through clinical trials.
Under this IDC, the University of Illinois has been awarded several task orders to support the NCI's Preclinical Prevent Cancer Program. These task orders include developing a dual AKT/PDPK1 inhibitor for actinic keratosis and skin cancer prevention in immunocompromised individuals ($2,273,213.36), supporting the clinical development of an HPV16L1/RG1 chimeric virus-like particle vaccine ($1,931,792.00), and providing contract orientation and kickoff meeting services ($2,587.19). The task orders do not have any set-aside designations and involve the University of Illinois delivering research, products, and services related to cancer prevention and vaccine development at locations in Illinois.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201500026I?
HHSN261201500026I was awarded to University Of Illinois by National Cancer Institute (National Institutes of Health) on September 22, 2015.
How much is contract HHSN261201500026I worth?
Orders under HHSN261201500026I have obligated $4,207,592. HHSN261201500026I's own ceiling is $19,000,000. A single order can be worth up to $5,000,000.
How many orders have been placed under contract HHSN261201500026I?
3 orders have been placed under HHSN261201500026I, the latest on September 17, 2018.
Who can order from contract HHSN261201500026I?
HHSN261201500026I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201500026I part of a contract vehicle?
Yes. HHSN261201500026I is part of PREVENT Toxicology and Pharmacology Testing (PREVENT TOX).
Was contract HHSN261201500026I competed?
The extent of competition for HHSN261201500026I was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV